148 related articles for article (PubMed ID: 3216516)
1. [L-asparaginase therapy against hybrid leukemia: a case report].
Mitani K; Kobayashi Y; Kawamura Y; Usuki K; Yuo A; Ishikawa F; Kitamura T; Ozawa K; Kitamura K; Urabe A
Rinsho Ketsueki; 1988 Sep; 29(9):1442-6. PubMed ID: 3216516
[No Abstract] [Full Text] [Related]
2. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
Charan VD; Desai N; Singh AP; Choudhry VP
Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
[No Abstract] [Full Text] [Related]
3. [Decreases in plasma antithrombin III, fibrinogen, factor IX, X and XI, fibronectin and thyroxine binding globulin during therapy with L-asparaginase, vincristine and prednisolone in a patient with CML blastic crisis].
Nishino H; Miura S; Hirai Y; Shigekiyo T; Kawauchi S; Takeichi T; Shirakami A; Saito S
Rinsho Ketsueki; 1984 Jun; 25(6):882-7. PubMed ID: 6434766
[No Abstract] [Full Text] [Related]
4. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
5. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G
Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263
[TBL] [Abstract][Full Text] [Related]
6. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukaemia presenting as breast mass.
Jain AK; Gupta RC; Bhardwaj B; Leelani N
J Assoc Physicians India; 1992 May; 40(5):335-6. PubMed ID: 1483996
[TBL] [Abstract][Full Text] [Related]
8. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
[TBL] [Abstract][Full Text] [Related]
9. Beau's lines after chemotherapy for ALL.
Miyoshi I; Kubota T; Taguchi H
Intern Med; 2007; 46(1):61. PubMed ID: 17202738
[No Abstract] [Full Text] [Related]
10. Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
Abdalla A; Badrawy F; Khalifa A; Hamza R
Chemioterapia; 1987 Jun; 6(2 Suppl):743-4. PubMed ID: 3509537
[No Abstract] [Full Text] [Related]
11. Acute lymphoblastic leukemia in infants.
Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G
Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738
[TBL] [Abstract][Full Text] [Related]
12. [Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia].
Matsuda I; Nakamaki T; Amaya H; Kiyosaki M; Kawakami K; Yamada K; Yokoyama A; Hino K; Tomoyasu S
Rinsho Ketsueki; 2003 Sep; 44(9):946-51. PubMed ID: 14577315
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
[TBL] [Abstract][Full Text] [Related]
15. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of 71 adult acute lymphoblastic leukemia].
Yoshida M; Kurata H; Tsunoda S; Iwama A; Suzuki T; Akutsu M; Imagawa S; Tsunoda J; Furukawa Y; Komatsu N
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1827-33. PubMed ID: 8379676
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the lymphoid blast crisis of chronic myeloid leukemia.
Bassan R; Battista R; Comotti B; Minetti B; Chisesi T; Dini E; Barbui T
Eur J Cancer Clin Oncol; 1987 May; 23(5):513-5. PubMed ID: 3477457
[TBL] [Abstract][Full Text] [Related]
18. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
[TBL] [Abstract][Full Text] [Related]
19. [Current status of the treatment of acute lymphocytic leukemia in the adult].
Shi YD; Zhang ZN
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
[No Abstract] [Full Text] [Related]
20. [Hand-mirror cells acute lymphoblastic leukemia (L3)].
Uemura K; Otani H; Sakamoto K; Sakanishi Y; Ota T; Kobayashi T; Ariyoshi N; Shirahata A
Rinsho Byori; 1995 Nov; 43(11):1173-7. PubMed ID: 8551683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
